Emory University/Children's Hospital of Atlanta — Atlanta, Georgia

Emory University/Children's Hospital of Atlanta is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Emory University/Children's Hospital of Atlanta has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Hematologic Malignancies, Hypoproliferative Thrombocytopenia, Cystic Fibrosis.

Sponsors: Terumo BCTbio, Emory University.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University/Children's Hospital of Atlanta?

Emory University/Children's Hospital of Atlanta has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University/Children's Hospital of Atlanta conducted?

Emory University/Children's Hospital of Atlanta has 2 clinical trials on record, with 1 currently active. Their work covers Hematologic Malignancies, Hypoproliferative Thrombocytopenia, Cystic Fibrosis.

Is Emory University/Children's Hospital of Atlanta accredited by Crixeo Clinical Trials?

Emory University/Children's Hospital of Atlanta has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University/Children's Hospital of Atlanta?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.